{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:16:30Z","timestamp":1791476190663,"version":"4.3.4"},"reference-count":61,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Triptolide (TP) is a major active component of colquhounia root tablet, which has been long been used in China to treat diabetic nephropathy (DN) due to its marked anti\u2011inflammatory, antiproteinuric, and podocyte\u2011protective effects. Methods: This study investigated the anti-proteinuria activity and related signaling cascade of TP in DN by utilizing a network pharmacology and molecular docking approach. Results: From the GeneCard, DisGeNET, and National Center for Biotechnology Information Gene databases, 1458 DN targets were obtained and input together with 303 TP targets into Venny2.1.0 for mapping and comparing. In total, 113 common targets of TP and DN were obtained, of which 7 targets were found to play an important role through theoretical inhibitory constant analysis. The common targets were further analyzed by Kyoto Encyclopedia of Genes and Genomes to identify the pathways related to the therapeutic effect of TP on DN. Among them, the seven targets were found to play key roles in six signaling pathways. The molecular docking results also showed TP had good binding ability to the seven targets. Conclusions: Analysis of the common targets and key pathways showed that TP can improve DN via its anti-nephritis, anti-renal fibrosis, antioxidant, and podocyte-protective effects, which might elucidate the mechanism by which TP improves renal function and reduces proteinuria in DN.<\/jats:p>","DOI":"10.31083\/j.fbl2703094","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T09:28:02Z","timestamp":1647595682000},"source":"Crossref","is-referenced-by-count":12,"title":["Prediction of the Potential Mechanism of Triptolide in Improving Diabetic Nephropathy by Utilizing A Network Pharmacology and Molecular Docking Approach"],"prefix":"10.31083","volume":"27","author":[{"given":"Xiaofei","family":"An","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, 210004 Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decai","family":"Fan","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Science, China Pharmaceutical University, 210009 Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Yin","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Science, China Pharmaceutical University, 210009 Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhan","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Science, China Pharmaceutical University, 210009 Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, 210004 Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruina","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, 210004 Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yan","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Science, China Pharmaceutical University, 210009 Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Cao Y, Yang Z, Chen Y, Jiang S, Wu Z, Ding B, et al. An Overview of the Posttranslational Modifications and Related Molecular Mechanisms in Diabetic Nephropathy. Frontiers in Cell and Developmental Biology. 2021; 9: 630401.","DOI":"10.3389\/fcell.2021.630401"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C, Muros de Fuentes M, Garc\u00eda-P\u00e9rez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews. Nephrology. 2011; 7: 327\u2013340.","DOI":"10.1038\/nrneph.2011.51"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang Q, Chen X, Liu Y, Xue J, Dahan A, et al. Revealing Synergistic Mechanism of Multiple Components in Gandi Capsule for Diabetic Nephropathy Therapeutics by Network Pharmacology. Evidence-Based Complementary and Alternative Medicine. 2018; 2018: 6503126.","DOI":"10.1155\/2018\/6503126"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Anders H, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nature Reviews. Nephrology. 2019; 14: 361\u2013377.","DOI":"10.1038\/s41581-018-0001-y"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Koch EAT, Nakhoul R, Nakhoul F, Nakhoul N. Autophagy in diabetic nephropathy: a review. International Urology and Nephrology. 2020; 52: 1705\u20131712.","DOI":"10.1007\/s11255-020-02545-4"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"A\/L B Vasanth Rao VR, Tan SH, Candasamy M, Bhattamisra SK. Diabetic nephropathy: an update on pathogenesis and drug development. Diabetes & Metabolic Syndrome. 2019; 13: 754\u2013762.","DOI":"10.1016\/j.dsx.2018.11.054"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hartman RE, Rao PSS, Churchwell MD, Lewis SJ. Novel therapeutic agents for the treatment of diabetic kidney disease. Expert Opinion on Investigational Drugs. 2020; 29: 1277\u20131293.","DOI":"10.1080\/13543784.2020.1811231"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Lv H, Jiang L, Zhu M, Li Y, Luo M, Jiang P, et al. The genus Tripterygium: a phytochemistry and pharmacological review. Fitoterapia. 2019; 137: 104190.","DOI":"10.1016\/j.fitote.2019.104190"},{"key":"ref9","unstructured":"Wan F, Tang YW, Tang XL, Li YY, Yang RC. TET2 mediated demethylation is involved in the protective effect of triptolide on podocytes. American Journal of Translational Research. 2021; 13: 1233\u20131244."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Zhao X, Tang X, Yan Q, Song H, Li Z, Wang D, et al. Triptolide ameliorates lupus via the induction of miR-125a-5p mediating Treg upregulation. International Immunopharmacology. 2019; 71: 14\u201321.","DOI":"10.1016\/j.intimp.2019.02.047"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Wang L, Zhang L, Hou Q, Zhu X, Chen Z, Liu Z. Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-kappaB\/GADD45B. Scientific Reports. 2018; 8: 10843.","DOI":"10.1038\/s41598-018-29203-1"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Wang D, Zhao X, Cui Y, Zhang T, Wang F, Hu Y. Efficacy and safety of Tripterygium wilfordii Hook F for CKD in Mainland China: a systematic review and meta-analysis. Phytotherapy Research: PTR. 2018; 32: 436\u2013451.","DOI":"10.1002\/ptr.5987"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Xiong C, Li L, Bo W, Chen H, XiaoWei L, Hongbao L, et al. Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR. Journal of the Formosan Medical Association. 2020; 119: 685\u2013692.","DOI":"10.1016\/j.jfma.2019.11.001"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Lengnan X, Ban Z, Haitao W, Lili L, Aiqun C, Huan W, et al. Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial. BioMed Research International. 2020; 2020: 981037.","DOI":"10.1155\/2020\/9181037"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Mou X, Zhou DY, Zhou D, Liu K, Chen LJ, Liu WH. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy. Phytomedicine. 2020; 69: 153192.","DOI":"10.1016\/j.phymed.2020.153192"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Song X, Zhang Y, Dai E, Du H, Wang L. Mechanism of action of celastrol against rheumatoid arthritis: a network pharmacology analysis. International Immunopharmacology. 2019; 74: 105725.","DOI":"10.1016\/j.intimp.2019.105725"},{"key":"ref17","unstructured":"Liu Z, Sun X. [Network pharmacology: new opportunity for the modernization of traditional Chinese medicine] Yao Xue Xue Bao. 2012; 47: 696\u2013703."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Fang T, Liu L, Liu W. Network pharmacology-based strategy for predicting therapy targets of Tripterygium wilfordii on acute myeloid leukemia. Medicine. 2020; 99: e23546.","DOI":"10.1097\/MD.0000000000023546"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Yuan H, Ma Q, Cui H, Liu G, Zhao X, Li W, et al. How can Synergism of Traditional Medicines Benefit from Network Pharmacology? Molecules. 2017; 7.","DOI":"10.3390\/molecules22071135"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Zhang R, Yu S, Bai H, Ning K. TCM-Mesh: the database and analytical system for network pharmacology analysis for TCM preparations. Scientific Reports. 2018; 7: 2821.","DOI":"10.1038\/s41598-017-03039-7"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research. 2019; 47: D607\u2013D613.","DOI":"10.1093\/nar\/gky1131"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Guo X, Ji J, Feng Z, Hou X, Luo Y, Mei Z. A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis. International Immunopharmacology. 2020; 80: 106201.","DOI":"10.1016\/j.intimp.2020.106201"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Guo M, Dai Y, Gao J, Chen P. Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology. Journal of Diabetes Research. 2020; 2020: 5947304.","DOI":"10.1155\/2020\/5947304"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research. 2004; 13: 2498\u20132504.","DOI":"10.1101\/gr.1239303"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Assenov Y, Ram\u00edrez F, Schelhorn S, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008; 24: 282\u2013284.","DOI":"10.1093\/bioinformatics\/btm554"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nature Communications. 2019; 10: 1523.","DOI":"10.1038\/s41467-019-09234-6"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Chai S, Huang X, Wu T, Xu S, Ren W, Yang G. Comparative genomics reveals molecular mechanisms underlying health and reproduction in cryptorchid mammals. BMC Genomics. 2021; 22: 763.","DOI":"10.1186\/s12864-021-08084-1"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Yu J, Yuan H, Bao L, Si L. Interaction between piperine and genes associated with sciatica and its mechanism based on molecular docking technology and network pharmacology. Molecular Diversity. 2021; 25: 233\u2013248.","DOI":"10.1007\/s11030-020-10055-9"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Bardou P, Mariette J, Escudi\u00e9 F, Djemiel C, Klopp C. Jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014; 15: 293.","DOI":"10.1186\/1471-2105-15-293"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Research 2000; 28: 235\u2013242.","DOI":"10.1093\/nar\/28.1.235"},{"key":"ref31","unstructured":"Sanner MF. Python: a programming language for software integration and development. Journal of Molecular Graphics & Modelling. 1999; 17: 57\u201361."},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Research. 2018; 46: D1074\u2013D1082.","DOI":"10.1093\/nar\/gkx1037"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Bhattacharjee N, Barma S, Konwar N, Dewanjee S, Manna P. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update. European Journal of Pharmacology. 2016; 791: 8\u201324.","DOI":"10.1016\/j.ejphar.2016.08.022"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Ye H, Wei J, Tang K, Feuers R, Hong H. Drug Repositioning through Network Pharmacology. Current Topics in Medicinal Chemistry. 2016; 16: 3646\u20133656.","DOI":"10.2174\/1568026616666160530181328"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ma R, Liu L, Liu X, Wang Y, Jiang W, Xu L. Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy. Experimental and Therapeutic Medicine. 2019; 6: 649\u2013656.","DOI":"10.3892\/etm.2013.1226"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Guo H, Pan C, Chang B, Wu X, Guo J, Zhou Y, et al. Triptolide Improves Diabetic Nephropathy by Regulating Th Cell Balance and Macrophage Infiltration in Rat Models of Diabetic Nephropathy. Experimental and Clinical Endocrinology & Diabetes. 2016; 124: 389\u2013398.","DOI":"10.1055\/s-0042-106083"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Li Z, Liu J, Wang W, Zhao Y, Yang D, Geng X. Investigation of hub genes involved in diabetic nephropathy using biological informatics methods. Annals of Translational Medicine. 2020; 8: 1087.","DOI":"10.21037\/atm-20-5647"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Zendjabil M. Glycated albumin. Clinica Chimica Acta. 2020; 502: 240\u2013244.","DOI":"10.1016\/j.cca.2019.11.007"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Vetter SW. Glycated Serum Albumin and AGE Receptors. Advances in Clinical Chemistry. 2015; 72: 205\u2013275.","DOI":"10.1016\/bs.acc.2015.07.005"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Choudhary GS, Al-Harbi S, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods in Molecular Biology. 2015; 1219: 1\u20139.","DOI":"10.1007\/978-1-4939-1661-0_1"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Mishra R, Emancipator SN, Kern T, Simonson MS. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney International. 2005; 67: 82\u201393.","DOI":"10.1111\/j.1523-1755.2005.00058.x"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Brezniceanu M, Lau CJ, Godin N, Ch\u00e9nier I, Duclos A, \u00c9thier J, et al. Reactive Oxygen Species Promote Caspase-12 Expression and Tubular Apoptosis in Diabetic Nephropathy. Journal of the American Society of Nephrology. 2010; 21: 943\u2013954.","DOI":"10.1681\/ASN.2009030242"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Panchapakesan U, Pollock C, Saad S. Renal epidermal growth factor receptor: its role in sodium and water homeostasis in diabetic nephropathy. Clinical and Experimental Pharmacology & Physiology. 2011; 38: 84\u201388.","DOI":"10.1111\/j.1440-1681.2010.05472.x"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Xu Z, Zhao Y, Zhong P, Wang J, Weng Q, Qian Y, et al. EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress. Oncotarget. 2017; 8: 32655\u201332667.","DOI":"10.18632\/oncotarget.15948"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Chuang PY, He JC. JAK\/STAT signaling in renal diseases. Kidney International. 2010; 78: 231\u2013234.","DOI":"10.1038\/ki.2010.158"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Said E, Zaitone SA, Eldosoky M, Elsherbiny NM. Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats. Chemico-Biological Interactions. 2018; 281: 111\u2013120.","DOI":"10.1016\/j.cbi.2017.12.030"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Zheng C, Huang L, Luo W, Yu W, Hu X, Guan X, et al. Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice. Cell Death & Disease. 2019; 10: 848.","DOI":"10.1038\/s41419-019-2085-0"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Chen Y, Qiao Y, Xu Y, Ling W, Pan Y, Huang Y, et al. Serum TNF-\u03b1 concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: a systematic review and meta-analysis. Immunology Letters. 2017; 186: 52\u201358.","DOI":"10.1016\/j.imlet.2017.04.003"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Navarro JF, Mora-Fern\u00e1ndez C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine & Growth Factor Reviews. 2006; 17: 441\u2013450.","DOI":"10.1016\/j.cytogfr.2006.09.011"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Vasylyeva TL, Chen X, Ferry RJ. Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis. Growth Hormone & IGF Research. 2005; 15: 207\u2013214.","DOI":"10.1016\/j.ghir.2005.02.008"},{"key":"ref51","unstructured":"Zhang SZ, Qiu XJ, Dong SS, et al. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1. European Review for Medical and Pharmacological Sciences. 2019; 23: 1248\u20131256."},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Wang X, Yao M, Liu S, Hao J, Liu Q, Gao F. Interplay between the Notch and PI3K\/Akt pathways in high glucose-induced podocyte apoptosis. American Journal of Physiology-Renal Physiology. 2014; 306: F205\u2013F213.","DOI":"10.1152\/ajprenal.90005.2013"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Sun Y, Liu W, Liu T, Feng X, Yang N, Zhou H. Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. Journal of Receptor and Signal Transduction Research. 2015; 35: 600\u2013604.","DOI":"10.3109\/10799893.2015.1030412"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Qiu Y, Tang L. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacological Research. 2016; 114: 251\u2013264.","DOI":"10.1016\/j.phrs.2016.11.004"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Jha JC, Banal C, Chow BSM, Cooper ME, Jandeleit-Dahm K. Diabetes and Kidney Disease: Role of Oxidative Stress. Antioxidants & Redox Signaling. 2016; 25: 657\u2013684.","DOI":"10.1089\/ars.2016.6664"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Wang Z, Zhang J, Chen L, Li J, Zhang H, Guo X. Glycine Suppresses AGE\/RAGE Signaling Pathway and Subsequent Oxidative Stress by Restoring Glo1 Function in the Aorta of Diabetic Rats and in HUVECs. Oxidative Medicine and Cellular Longevity. 2019; 2019: 4628962.","DOI":"10.1155\/2019\/4628962"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Sanajou D, Ghorbani Haghjo A, Argani H, Aslani S. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. European Journal of Pharmacology. 2018; 833: 158\u2013164.","DOI":"10.1016\/j.ejphar.2018.06.001"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Xue M, Cheng Y, Han F, Chang Y, Yang Y, Li X, et al. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition via the MiR-188-5p-mediated PI3K\/AKT Pathway in Diabetic Kidney Disease. International Journal of Biological Sciences. 2018; 14: 1545\u20131557.","DOI":"10.7150\/ijbs.24032"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Xie X, Xia W, Fei X, Xu Q, Yang X, Qiu D, et al. Relaxin Inhibits High Glucose-Induced Matrix Accumulation in Human Mesangial Cells by Interfering with TGF-\u03b21 Production and Mesangial Cells Phenotypic Transition. Biological & Pharmaceutical Bulletin. 2015; 38: 1464\u20131469.","DOI":"10.1248\/bpb.b15-00127"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Kato M, Yuan H, Xu Z, Lanting L, Li S, Wang M, et al. Role of the Akt\/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. Journal of the American Society of Nephrology. 2006; 17: 3325\u20133335.","DOI":"10.1681\/ASN.2006070754"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Abouzed TK, Sadek KM, Ghazy EW, Abdo W, Kassab MA, Hago S, et al. Black mulberry fruit extract alleviates streptozotocin-induced diabetic nephropathy in rats: targeting TNF-\u03b1 inflammatory pathway. Journal of Pharmacy and Pharmacology. 2020; 72: 1615\u20131628.","DOI":"10.1111\/jphp.13338"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/3\/10.31083\/j.fbl2703094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:47:07Z","timestamp":1732708027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/3\/10.31083\/j.fbl2703094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2768-6701(22)00432-4"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2703094","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"article-number":"94"}}